NCT07380503Completed
Analgesic Efficacy of Adding Different Doses of Dexmedetomidine as Adjuvants With Bupivacaine vs.Bupivacaine Only in Ultrasound-guided Erector Spinae Plane Block in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery. A Randomized Controlled Double Blinded Study.
Source: ClinicalTrials.gov · Last updated 9 Mar 2026
Brief summary (registry, in English)
Analgesic Efficacy of adding different doses of dexmedetomidine as adjuvants with bupivacaine vs. bupivacaine only in ultrasound-guided erector spinae plane block in morbidly obese patients undergoing Laparoscopic Bariatric surgery. A RANDOMIZED CONTROLLED DOUBLE BLINDED STUDY.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 78 (actual)
- First submitted
- 20 Nov 2025
- Start date
- 1 Jan 2025
- Primary completion date
- 30 Aug 2025
- Lead sponsor
- Cairo University
- Diseases
- Obesity
- NCT number
- NCT07380503
What you commit to
- Study type: Observational
- Participants enrolled: 78
- From 1 Jan 2025 to the primary completion date, 30 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known allergy to local anesthetics and adjuvant drugs used (dexamedatomedine)
- Neurological disorders
- Patient with psychiatric disorders
Lab values
- Bleeding disorders; platelets count \<50,000, prothrombin concentration \< 60% or any coagulopathy disorder.
Other
- Patient refusal
- Use of any anti-coagulants
- Inability to provide informed consent
- ASA -IV
- Failed block is claimed if the patient required more than 2 doses of rescue analgesia in the first 2 hrs post operative , failed block cases will be recorded , excluded and managed according to the institutional regulations (opioid analgesia).
Who the study is looking for
- Age starting from 21 to 60 years.
- Genders eligible for study: Male and female sexes.
- ASA I-III
- Undergoing Laparoscopic bariatric surgery.
- BMI \> = 40.
Age in the registry: 21 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ahmed Abdalla Mohamed Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.